Hormone Replacement Therapy and Cardiovascular Disease: The Current Status of Research and Practice

Front Cover
A.R. Genazzani
CRC Press, May 15, 2001 - Medical - 200 pages
This is a high-level, clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopausal hormone replacement therapies such as Livial (tibolone). This volume is based on the formal presentations and subsequent discussions that took place at the International Menopause Society specially convened Expert Workshop on Hormone Replacement Therapy and Cardiovascular Disease, London, UK, October 13-16, 2000.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Lipid metabolism
27
role of gender
47
Acute coronary syndromes in women
63
The estrogen receptor knockout mouse model
81
actions in animal models
101
Sex steroids and blood coagulation
117
the role of lecithin cholesterol acyltransferase and
127
Cardiovascular effects of available hormone replacement therapy
133
Aerodiol
155
Cardiovascular risk assessment for postmenopausal hormone replacement therapies
165
primary
173
Copyright

Common terms and phrases

Bibliographic information